Ratings by Guggenheim (Adnan Butt)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/18/2019 | Aerpio Pharmaceuticals | ARPO | Downgrade | Neutral (Buy) |
4.25 (2.20) |
-48.24% | Details | |
| 1/4/2019 | Regeneron Pharma | REGN | Upgrade | Buy (Neutral) |
372.44 (422.51) |
13.44% | Details | |
| 12/4/2018 | Ocular Therapeutix | OCUL | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2018 | The Medicines Company | MDCO | Maintain | Buy (N/A) |
|
Details | ||
| 10/3/2018 | Paratek Pharmaceuticals | PRTK | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2018 | Aerpio Pharmaceuticals | ARPO | New Coverage | Buy (N/A) |
3.52 (4.25) |
20.74% | Details | |
| 9/6/2018 | Spectrum Pharmaceuticals | SPPI | Maintain | Buy (N/A) |
|
Details |
